Annual Drug Patent Expirations for SYMTUZA
Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for SYMTUZA.
This drug has five hundred and eigthy-three patent family members in fifty-nine countries.
The generic ingredient in SYMTUZA is cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate. One supplier is listed for this compound. Additional details are available on the cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
